ARTICLE | Company News
Open Monoclonal Technology, J&J deal
January 7, 2013 8:00 AM UTC
On Dec. 21, 2012, Open Monoclonal Technology said it and the CNA Development LLC affiliate of Janssen Pharmaceuticals Inc. partnered to generate antibodies against undisclosed targets from Janssen. Op...